MetaVia Inc

Research MetaVia Inc (MTVA) on Bullrun: market cap USD 7.69M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMTVA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.69M
• Financial periodFY2025
• Net income-USD 12.97M
• Free cash flow-USD 15.70M

Valuation Snapshot

latest market cap is USD 7.69M.

About MetaVia Inc

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus;

Frequently asked questions

What is MetaVia Inc's market cap?

MetaVia Inc's market capitalization is USD 7.69M.

What does MetaVia Inc do?

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.